Andrew Hollman Meyer, Chief Business Officer: Janux Therapeutics JANX Sell · Filed 24/09/27

Trade details

Type: Insider sale
Amount: $2,298,000
Shares · price: 50,000 sh · $45.96 a share
Held after: 67,592 sh
Stock: Janux Therapeutics JANX
Person: Andrew Hollman MeyerChief Business Officer
Trade date: 24/09/27
Filed: 24/09/27
Days to filing: 0 days

Sold 42.5% of holdings

Share of holding sold: 42.5%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/28~24/10/27

Andrew Hollman Meyer's recent trades

Andrew Hollman MeyerChief Business Officer
Planned saleJanux Therapeutics
Planned sale
Janux Therapeutics
JANX
$28.2K
1,877 sh
$28.2K
Filed 04/13
Traded 04/13
Andrew Hollman MeyerChief Business Officer
Planned saleJanux Therapeutics
Planned sale
Janux Therapeutics
JANX
$2.6M
178,767 sh
$2.6M
Filed 01/26
Traded 01/26
Andrew Hollman MeyerChief Business Officer
Planned saleJanux Therapeutics
Planned sale
Janux Therapeutics
JANX
$1.7M
118,122 sh
$1.7M
Filed 01/23
Traded 01/23
Andrew Hollman MeyerChief Business Officer
SellJanux Therapeutics
Sell
Janux Therapeutics
JANX
$25.8K
1,879 sh
$25.8K
Filed 01/02
Traded 01/02
Andrew Hollman MeyerChief Business Officer
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$88.7K
2,700 sh
$88.7K
Filed 25/12/03
Traded 25/12/01